Health Research Grants

NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.

Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.

Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by NSF CISE. Supports the development of transformative high-risk, high-reward advances in computer and information science, engineering, mathematics, statistics, behavioral and/or cognitive research to address pressing questions in the biomedical and public health communities.

Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.

The Biomedical Catalyst – Industry-led R&D (Small Projects) is a grant from Innovate UK (part of UKRI) that funds the development of innovative solutions to health and healthcare challenges. The programme supports small-scale industry-led R&D projects and is open to both single applicants and collaborative teams. Eligible applicants are UK-registered micro, small, and medium-sized enterprises (SMEs). A total of up to £25 million is available across the competition, with applications closing on 10 December 2025. To lead or work alone on a project, organisations must hold UK SME status and register through the Innovation Funding Service.

Developing Agency, Identity and Belonging in Young People is sponsored by The Colorado Health Foundation. Provides support for programs that offer safe, welcoming spaces for youth (BIPOC, LGBTQIA2S+, etc.) to develop relationships, community connection, and resilience outside of school or home. Geographic focus: Colorado Focus areas: Thriving Young People, Health Equity, Social-Emotional Development

The Bicycle Helmet Initiative is a grant from the North Carolina Department of Transportation that funds organizations distributing free bicycle helmets to promote cyclist safety across the state. The program provides 25 to 100 helmets per recipient, valued at approximately $500 to $2,000. Eligible applicants include North Carolina government entities, nonprofits, schools, churches, and public health agencies committed to bicycle safety education and outreach. The most recent application deadline was February 20, 2026. This initiative supports the state's broader Safe Routes to School and pedestrian and bicycle safety goals by ensuring cost is not a barrier to helmet access for North Carolina communities.

Connected Healthy Lives Grant Cycle is a grant from the Humana Foundation that funds organizations advancing health equity through innovative programs addressing the social determinants of health. The Humana Foundation directs its grantmaking around four core commitment areas, with a Health Equity Innovation Fund supporting bold, transformative approaches. Grants range from $50,000 to $2,500,000, with single-year and multi-year proposals accepted. Applicants must establish an organizational profile and complete an eligibility check through the Humana Foundation's SmartSimple grant management portal before submitting a proposal.

Colorado Energy Efficiency Business Rebate Program is a grant from the Colorado Department of Public Health and Environment that funds energy efficiency upgrades for small businesses in eligible Colorado communities. The program provides rebates for improvements such as LED lighting installations and commercial refrigeration equipment replacement. Awards are available up to $10,000 per business. Initially available in Aurora and Commerce City, with potential expansion to additional communities. Eligible applicants are Colorado-based small businesses operating in participating communities whose projects focus on qualifying energy efficiency upgrades. The program deadline was March 1, 2026.

NSF 25-509: Emerging Mathematics in Biology (eMB) is a grant from NSF that funds integrative research projects applying innovative mathematical theories and techniques to significant biological questions. The program supports truly interdisciplinary work at the interface of mathematics, biology, and public health, encouraging novel use of mathematical tools to advance biological understanding and inform public health policy. Eligible applicants include accredited two- and four-year institutions of higher education with campuses in the United States. Full proposals are due March 1 annually, with total funding ranging from $2 million to $6 million across multiple awards.

AI for Health Seed Funding Program is sponsored by AI for Health Institute and Washington University in St. Louis Research Development Office. This seed grant program supports innovative and interdisciplinary research that leverages artificial intelligence (AI) to address critical challenges in health. It is designed to catalyze collaborations across disciplines, encouraging the integration of AI with public health and healthcare, and requiring projects to bring together researchers from AI and health domains.

The Maryland Department of Health Addressing Disparities in Social Determinants of Health (SDOH) and Obesity in Maryland Communities Program is a grant from the Maryland Department of Health that funds community-based interventions targeting health disparities, social determinants of health, and obesity among racial and ethnic minorities in Maryland. The program descends from the legacy Minority Outreach and Technical Assistance (MOTA) initiative established in 2001 and focuses on chronic disease prevention, education, and outreach. The FY27 RFA deadline was March 11, 2026. Eligible applicants are organizations providing community-based health interventions to underserved populations in Maryland.

Health Equity Scholars for Action is sponsored by Robert Wood Johnson Foundation. The goal of HES4A is to support the career development and academic progress of faculty conducting health equity research, particularly early-career researchers systemically underrepresented in health sciences and related fields. Projects focus on transformative, action-oriented evidence addressing structural barriers and are aligned with RWJF's mission to achieve equity.

The NIA Academic Leadership Career Award (K07, No Independent Clinical Trial) is a career development award from the National Institute on Aging (NIH) that supports established investigators who want to expand their expertise in aging-related research and academic leadership. Awards provide up to $150,000 per year to fund protected research and mentoring time. Eligible applicants are investigators with a doctoral degree (PhD, MD, or equivalent) who are named PD/PI on an active R01 or equivalent NIA grant, devote 25-50% full-time professional effort to the award, and are U.S. citizens or permanent residents. The application deadline is March 20, 2026.

Mobile Health (mHealth): Technology and Outcomes in Low and Middle Income Countries is a grant from the Fogarty International Center at NIH that funds research on mobile health technologies and their outcomes in low and middle income countries. Administered as an R21/R33 Phased Innovation Award, this funding opportunity supports studies that leverage mHealth tools to address health challenges in resource-limited settings. Participating NIH components include FIC, NEI, NIBIB, NICHD, NIDCD, NIMH, and NCI. Applications must align with the mission of the participating institutes. The program accommodates clinical trial optional designs. Award amounts vary by application and institute. The deadline for the most recent cycle was March 20, 2026.

Postdoctoral Research Fellowship Program – Basic and Preclinical Science is a grant from the Charles A. King Trust that supports mid- to late-stage postdoctoral fellows and mentored clinician scientists conducting basic and preclinical biomedical research in Massachusetts. The program funds researchers at a critical career juncture, providing resources for independent scientific investigation. The 2026 Full Stage Application deadline was March 25, 2026, with invitations sent February 12, 2026. Eligible applicants must be senior postdoctoral researchers or mentored clinician scientists based at research institutions in Massachusetts.

The Massachusetts Community Health and Healthy Aging Funds 2026 is a grant from the Massachusetts Department of Public Health and Health Resources in Action that funds organizations addressing health disparities and age-friendly community development across the Commonwealth. The program supports Policy, Systems, and Environmental (PSE) changes that tackle root causes of inequitable health outcomes including structural racism, poverty, and power imbalances. Three funding streams are available: PSE Change, Community Health Improvement Planning (CHIP), and Healthy Aging, which aligns with Massachusetts' ReiMAgine Aging 2030 plan. Eligible applicants include Massachusetts-based nonprofit organizations, municipalities, quasi-governmental groups, and coalitions. Award amounts vary between planning and full implementation grants. The deadline to apply is March 31, 2026.

The Evidence for AI in Health (EVAH) initiative is a $60 million joint investment by the Gates Foundation, Novo Nordisk Foundation, and Wellcome Trust to support rigorous, country-led evaluations of AI health tools in low- and middle-income countries. Delivered in partnership with J-PAL and the African Population and Health Research Center, EVAH funds evaluations of AI-enabled clinical decision support tools in primary and community healthcare settings across Sub-Saharan Africa, South Asia, and Southeast Asia. Pathway A supports early-deployment evaluations focusing on usability, workflow integration, and safety for up to $1 million. Pathway B funds randomized controlled trials, economic analyses, and implementation science studies of tools ready for deployment at scale for up to $3 million. The initiative addresses a critical evidence gap about whether AI diagnostic and clinical decision support tools actually improve health outcomes in resource-limited settings.

Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). NIAMS intends to publish a NOFO for research on ancillary studies that leverage resources from ongoing parent clinical studies (e.g., patient cohorts, infrastructure, data, biological samples). While parent studies can be outside the NIAMS mission, the ancillary study itself must align with the NIAMS mission.

The FDT-BioTech program is a joint NSF NIH and FDA initiative that catalyzes biomedical technological innovation through foundational development of methods and algorithms relevant to digital twins and synthetic humans. The program supports inherently interdisciplinary research projects that underpin the mathematical and engineering foundations behind the development and use of digital twins and synthetic data in biomedical and healthcare applications with a particular focus on digital in silico models used in the evaluation of medical devices and to advance regulatory sciences. Priority research areas include computational representations of physiological systems verification validation and uncertainty quantification transferability and generalizability across populations ethics security and privacy considerations and validation mechanisms for digital twin models. The program incorporates AI and machine learning as key enabling technologies for creating responsive digital twin models. All proposals must address regulatory science benefits and ethical implications. This program is distinct from the NSF SCH Smart Health program which focuses broadly on AI for health research and from ARPA-H programs which target specific clinical applications.

NSF FDT-BioTech Foundations for Digital Twins as Catalyzers of Biomedical Technological Innovation is sponsored by National Science Foundation, National Institutes of Health, and Food and Drug Administration. The NSF FDT-BioTech program, a joint initiative of the National Science Foundation, National Institutes of Health, and the Food and Drug Administration, supports inherently interdisciplinary research projects that underpin the mathematical and engineering foundations behind the …

The NSF FDT-BioTech program (NSF 24-561) supports interdisciplinary research at the intersection of AI, computational modeling, and biomedical innovation by funding the mathematical and engineering foundations behind digital twins and synthetic data for healthcare applications. Digital twins — computational replicas of biological systems, patients, or medical devices — require advanced AI and machine learning methods for their development, calibration, and deployment. The program funds research on methods and algorithms relevant to digital twins and synthetic humans, including AI-driven in silico evaluation of medical devices and treatments. Projects must be inherently interdisciplinary, combining expertise in mathematics, engineering, computer science, and biomedical domains. Collaborative projects across multiple organizations are encouraged and can receive up to $1 million in total funding over up to 3 years. The program is administered by multiple NSF directorates including the Division of Mathematical Sciences and the Office of Advanced Cyberinfrastructure, reflecting its cross-cutting nature. The deadline recurs annually on the first Monday in May.

Notice of Special Interest (NOSI): Encouraging Women's Health Research within the NIDCD Mission Areas is sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD) / National Institutes of Health (NIH). This notice solicits grant applications seeking to improve women's health across the lifespan within the scope of NIDCD's mission.

Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) is sponsored by U.S. Department of Health and Human Services; Office of Research on Women's Health; 3 more sponsors. This grant supports collaborative research to address Non-Communicable Disease (NCD) health disparities among Latin American and U. S. Hispanic/Latino populations, emphasizing innovative interventions and international partnerships.

The Trailblazer Award for New and Early Stage Investigators (R21) is a grant from the National Institutes of Health, administered by the National Institute of Biomedical Imaging and Bioengineering and partner ICs, that funds exploratory biomedical and bioengineering research led by new and early-stage investigators. The program encourages unconventional, high-risk and high-reward approaches in imaging, bioengineering, and health informatics. Eligible applicants must be new or early-stage investigators who have not previously served as principal investigator of an NIH R01 or equivalent award. Clinical trials are permitted under this mechanism.

The Wellcome Mental Health Data Prize UK 2026-2028 supports the development of data tools and AI solutions contributing to improving early intervention for anxiety, depression, and psychosis. This prize program, managed in partnership with Social Finance, funds teams to develop innovative data science and AI tools that can identify individuals at risk of mental health conditions earlier and connect them with appropriate interventions. The prize builds on Wellcome's broader mental health science priorities and complements their separate generative AI mental health research program. Previous rounds funded teams at approximately £200,000 each. The UK 2026 round accepts applications until May 8, 2026 at 12pm. The prize program has previously operated in Africa (2024-2026 with £200,000 per team) and globally (2022-2023 with £1.4 million total). Contact: dataprize@wellcome.org.

NOAA's Competitive Research Program: Harmful Algal Bloom Innovation Challenge — Toxin Detection in Seafood is a grant from the National Oceanic and Atmospheric Administration (NOAA) that funds research and development of innovative methods for detecting harmful algal bloom (HAB) toxins in seafood. The program addresses a critical public health and food safety challenge, supporting approaches that improve the speed, accuracy, or accessibility of toxin detection in commercially and recreationally harvested seafood products. Eligible applicants include U.S. institutions of higher education, non-profit organizations, state and local governments, tribal entities, U.S. territories, and for-profit organizations. The application deadline is May 14, 2026. Award amounts are not publicly specified in the source materials.

Massachusetts Urban Agriculture Program is a grant from the Massachusetts Department of Agricultural Resources (MDAR) that funds commercial projects to increase the production, processing, and marketing of produce in urban areas across the Commonwealth. Priority areas include soil management, land acquisition, farm equipment, marketing and distribution, green infrastructure, innovative growing technologies like aquaponics and vertical farming, and organic farming transitions. Projects must represent long-term capital investments and foster youth development, small business development, and job training. Eligible applicants include 501(c)(3) nonprofit organizations, public or nonprofit educational or public health institutions, and established urban farmers with more than three years of commercial urban farming experience. Recent awards ranged from $20,000 to $30,000. Backyard produce or livestock raised for personal consumption is not funded.

LAUNCH Program is sponsored by National Institutes of Health (NIH). The LAUNCH program supports the training of future global health researchers by providing early career researchers in the U.S. an opportunity for immersion in the wide-ranging health conditions and challenges experienced in international low-resource settings and to partner with local health researchers.

The Alcohol Research Education Programs (R25) is a grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) that funds research education activities for health professionals focused on alcohol and other substance use disorders. Co-sponsored by NIDA, the program aims to attract health professionals to research careers in alcohol and substance use, improve their understanding of evidence-based treatment, and enhance clinical training programs. Eligible applicants include higher education institutions, nonprofits, and state/local governments. Awards provide up to $250,000 per year. The application deadline is May 25, 2026. Clinical trials are not allowed under this funding mechanism.

The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer, stem cell therapy trials, and other complex or high resource- or safety-risk clinical trials. These projects are multifaceted and of high public health significance requiring clear delineation of study organization including roles and responsibilities and require careful performance oversight and monitoring. For purposes of this Notice of Funding Opportunity (NOFO), the proposed study must be intended to evaluate interventions aimed at screening, diagnosing, preventing, or treating vision disorders, or to compare the effectiveness of two or more established interventions. The NEI UG1-supported studies are typically funded as a group of single-component companion grant awards including the Chairs Grant, the Coordinating Center, and Resource Centers, when appropriate. Specifically, this NOFO encourages applications for the Chair's grant, which includes the scientific rationale, study aims and significance of the research project. Funding Opportunity Number: PAR-23-209. Assistance Listing: 93.867. Funding Instrument: CA. Category: HL.

NLM Information Resource Grants to Reduce Health Disparities and Promote Health for All (G08 Clinical Trial Not Allowed) is sponsored by National Library of Medicine (NIH). This funding opportunity supports the development of information resources and services that provide accurate health information to populations experiencing health disparities and their providers, to improve health literacy, decision-making, and reduce disparities.

Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health, Office of Research Infrastructure Programs. This grant supports the development of broad-impact human health and disease models and resources for biomedical research, applicable across multiple NIH institutes.

Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed) is sponsored by U.S. Department of Health and Human Services; Office of Research Infrastructure Programs (United States); National Institutes of Health. This grant supports the development of broad-impact human health and disease models and resources for biomedical research, applicable across multiple NIH institutes.

The NIH Office of Research on Women's Health (ORWH) and participating NIH Institutes and Centers invite institutional career development award applications for Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Career Development Programs, hereafter termed "Programs". Programs will support mentored research career development of junior faculty members, known as BIRCWH Scholars, who have recently completed clinical training or postdoctoral fellowships, and who will be engaged in interdisciplinary basic, translational, behavioral, clinical, and/or health services research relevant to the health of women and, where appropriate, the use of both sexes to better understand the influence of sex as a biological variable on health and disease. This Funding Opportunity Announcement (FOA) allows appointment of Scholars (K12) proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary clinical trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development. Funding Opportunity Number: RFA-OD-24-013. Assistance Listing: 93.121,93.273,93.279,93.313,93.398,93.846,93.855,93.866. Funding Instrument: G. Category: ED,HL. Award Amount: Up to $840K per award.

Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant (NRSA) for Primary Medical Care (HRSA-26-036) is sponsored by Health Resources and Services Administration (HRSA). This program aims to develop a skilled research workforce to advance scientific knowledge in primary care by providing support for postdoctoral healthcare professionals who plan to pursue careers in biomedical and behavioral health research related to primary care. These HRSA T32 awards are made to eligible institutions to develop or enhance postdoctoral research training opportunities for these individuals.

Drinking Water State Revolving Fund (DWSRF) is a financial assistance program from NYS EFC and NYS Department of Health providing low-interest loans and grants to upgrade drinking water infrastructure in New York State. Eligible borrowers include community water systems and nonprofit non-community water systems. Projects must be listed on the Department of Health's Intended Use Plan (IUP) before applying. The program prioritizes projects addressing public health risks, aging infrastructure, and emerging contaminant compliance, with enhanced funding available through the Infrastructure Investment and Jobs Act.

Asthma Home Visit Collaborative (HVC) Grant Program is sponsored by Illinois Department of Public Health. This program aligns with the CDC's Controlling Childhood Asthma and Reducing Emergencies (CCARE) initiative and EXHALE Technical Package. It aims to improve childhood asthma outcomes and prevent hospitalizations and emergency department visits through in-person or virtual home visiting services and the implementation of evidence-based EXHALE strategies.

Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (RFA-EB-26-003) is sponsored by National Institutes of Health (NIH), National Institute of Biomedical Imaging and Bioengineering (NIBIB). This Notice of Funding Opportunity (NOFO) solicits applications to enhance bioengineering and imaging research capacity, technology innovation, education and research training, and opportunities for scientific growth at Historically Black College and Universities (HBCUs).

Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) (PAR-25-342) is sponsored by National Institutes of Health (NIH). This opportunity funds research on interventions addressing health and healthcare disparities related to non-communicable and chronic diseases in Latin America, with the goal of improving health outcomes.

Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed) is sponsored by National Institutes of Health. This NIH grant opportunity focuses on research into health and healthcare disparities in non-communicable and chronic diseases in Latin America.

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) is sponsored by National Cancer Institute (NCI), National Institutes of Health (NIH). This funding opportunity invites investigator-initiated studies addressing mechanisms by which incretin mimetics, specifically GLP-1 or dual GLP-1/GIP-1 receptor agonists, impact cancer risk. The focus includes reported effects on thyroid, prostate, and other cancer risks. The NOFO also aims to attract scientists from other fields to study incretin mimetic effects on cancer biology.

Innovative Mental Health Services Research Not Involving Clinical Trials (R01) is a grant from the National Institute of Mental Health (NIMH) that funds research investigating the effectiveness, implementation, and dissemination of mental health services outside of clinical trial settings. The program supports studies examining how mental health care is delivered, accessed, and experienced across diverse populations and settings. Eligible applicants include public and private higher education institutions, nonprofits, and research organizations in the United States and internationally. Award amounts vary based on project scope, with applications due June 5, 2026.

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) is sponsored by U.S. Department of Health and Human Services; National Library of Medicine; National Institutes of Health (NIH). This program supports innovative, scalable bioinformatics research with broad biomedical impact. This can include AI applications within bioinformatics, translational bioinformatics, and computational biology.

Research Grants in Clinical Informatics (R01 Clinical Trial Optional) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health. This NIH funding opportunity supports innovative clinical informatics research to transform health data into actionable knowledge. AI and ML are often key components in advancing clinical informatics.

Research Grants in Clinical Informatics (R01 Clinical Trial Optional) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health (NIH). This NIH funding opportunity supports innovative clinical informatics research to transform health data into actionable knowledge. While broad, it can include projects leveraging AI for data analysis and integration to advance biomedical research.

Research Council of Finland (RCF) – National Institutes of Health (NIH) Partnership Program (PA-26-085) is sponsored by NIH Fogarty International Center. This program funds collaborative health research projects between U.S. and Finnish universities. While not explicitly focused on traditional medicine or complementary health, research in global health could be part of the collaborative projects.

Research Project Grant (Parent R01 Clinical Trial Required) is sponsored by National Institute on Aging (NIA). This is a broad funding opportunity for research projects, and the NIA supports and conducts research to understand the nature of aging and extend healthy, active years of life, including research on age-related diseases and conditions.

Grants Supporting Women's Health Research and Education Initiatives is sponsored by The Grant Portal (aggregator, but program likely real based on summary). Funding opportunity for nonprofit organizations, academic institutions, and healthcare or advocacy groups working in women's health and public health. This could potentially include studies on body composition in relation to women's health.

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) is sponsored by U.S. Department of Health and Human Services; National Library of Medicine (NLM); National Institutes of Health. This NIH funding opportunity, with NLM participation, supports innovative, scalable bioinformatics research with broad biomedical impact. This could include developing computational tools and methods for analyzing and integrating exposome data using AI.

Great Plains Center for Agricultural Health Pilot/Feasibility Projects Academic Track is sponsored by Great Plains Center for Agricultural Health. Grants for academic/scientific investigators and those newly interested in agricultural safety and health research. Funding supports projects addressing occupational hazards relevant to farmers and farm workers in the Great Plains region, with a focus on work-related stress and mental health, prevention of slips, trips, and falls, equipment/tool safety, and chemical safety.

Multimodal Digital Biomarkers Grant is sponsored by Labfront (supported by Zana). This joint grant funds researchers combining wearable-derived physiological data with voice biomarkers across two tracks: Cardiopulmonary Extension and Open Innovation (including mental health, sleep, occupational health, and neurological conditions). While not exclusively health equity AI, it strongly supports wearable technology and advanced data analysis for health insights, which can be applied to health equity research.

BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) is sponsored by U.S. Department of Health and Human Services; National Institutes of Health. BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24) is a grant from the National Institutes of Health that supports dissemination of resources for integration into neuroscience research practice.

Standardizing Data and Metadata from Wearable Devices (R01 Clinical Trial Not Allowed) is sponsored by National Institute of Mental Health (NIMH). This funding opportunity supports the creation of standards for data and metadata from wearable devices and cell phones to promote re-use and integration of this data by researchers. The goal is to facilitate secondary data analysis and the development of software packages and workflows, which is crucial for advancing health equity research using wearable data. Applicants are expected to partner with device manufacturers and the research community.

BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) is sponsored by U.S. Department of Health and Human Services; National Institutes of Health; Office of Behavioral and Social Sciences Research. This funding opportunity promotes the rapid dissemination of validated neurotechnologies to the neuroscience community, supporting a wide range of organizations.

Scholarships for Health Professions Students from Disadvantaged Backgrounds is sponsored by Health Resources and Services Administration (HRSA). This program promotes diversity among health professions students and practitioners by providing scholarships to students from disadvantaged backgrounds who have financial need and are enrolled, or accepted for enrollment, as full-time students at eligible health professions sch…

SNF Global Center Research Fellowship Program is sponsored by Stavros Niarchos Foundation Global Center for Child and Adolescent Mental Health at the Child Mind Institute. This competitive funding and career development initiative supports early-career researchers in low- and middle-income countries (LMICs) who are advancing child and adolescent mental health research. The program focuses on research that responds directly to local community needs and supports long-term research projects, training, mentorship, and international collaboration. Fellows will lead independent research projects as principal investigators.

Beckman Scholars Program is sponsored by Arnold and Mabel Beckman Foundation. The purpose of the Beckman Scholars Program is to help stimulate, encourage, and support research activities by talented, full-time undergraduate students who are pursuing their studies at accredited four-year colleges and universities located in the United States of America.

NIBIB Trailblazer Award for New and Early Stage Investigators (R21) is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB). This grant is for early-stage researchers to pursue projects at the intersection of engineering and the physical sciences with life sciences. It is ideal for high-risk, high-impact medical device research where preliminary data is not required.

R21 Exploratory/Developmental Grant is a grant from the National Institutes of Health (NIH) that funds early-stage, high-risk research projects across biomedical and behavioral science categorical program areas. Awards support projects of up to two years with a maximum of $275,000 in total direct costs, with no more than $200,000 in any single year. Preliminary data are not required for most opportunities. Research strategies may not exceed six pages. Multiple NIH institutes and centers participate, and investigators should consult NIH scientific staff during concept development to confirm that the R21 mechanism is appropriate for their project.

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) is sponsored by National Center for Advancing Translational Sciences (NCATS)/National Institutes of Health (NIH). This R03 grant supports pilot projects that investigate understudied proteins associated with rare diseases. Leukodystrophies are rare diseases, and research into the proteins involved in their pathogenesis would be highly relevant.

Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) is sponsored by National Institutes of Health (NIH). The NIH offers various funding opportunities for behavioral and social sciences research. While this specific R21 announcement title doesn't explicitly mention 'consumer behavior marketing science,' R21 grants support exploratory/developmental research, and consumer behavior aspects could be relevant within broader translational science, especially related to health behaviors. Researchers are encouraged to filter announcements by agency, topic, eligibility, or deadline on Grants.gov.

Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) is sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD) / NIH. This funding opportunity supports early-stage dissemination and implementation (D&I) research projects in NIDCD mission areas, including hearing and balance. It aims to support projects that will set a foundation for a high-quality, D&I focused R01.

NCATS program (PAR-25-157) supporting development of innovative technologies for translational science including AI/ML-driven drug discovery, high-throughput screening automation, computational target identification, and novel assay platforms. Funds exploratory research that creates new tools, methods, and technologies to overcome specific translational bottlenecks in the drug development pipeline. Part of NCATS' broader mission that has enabled over 45 promising new drugs to move into clinical trials through partnerships with academia, industry, and patient advocacy groups. NCATS maintains a pharmaceutical collection of nearly every human-approved drug and automated solutions for rapid drug repurposing screening including for emerging infectious diseases.

The Rural Health Transformation Program (RHTP) is a grant from the Missouri Department of Social Services (DSS) that funds systemic, long-term improvements to healthcare in rural communities across Missouri. Established by Public Law 119-21, this five-year, $50 billion federal investment addresses hospital closures, healthcare worker shortages, and poor health outcomes in rural areas. Missouri's DSS leads the state application alongside the Department of Health and Senior Services and Department of Mental Health. Funded activities span five strategic goals: prevention and chronic disease management, rural health network sustainability, healthcare workforce development, community health hubs, and healthcare technology adoption. Eligible applicants include rural healthcare organizations, hospitals, clinics, community-based organizations, local public health agencies, and other rural health providers in Missouri, with Hub Anchor applicants serving approximately 3–5 county regions. The total Missouri allocation is $216,276,817.66, with a deadline of June 18, 2026.

Local Public Health Infrastructure Grant Program 2027 is sponsored by New Jersey Department of Health. This program, offered by the New Jersey Department of Health, aims to strengthen public health infrastructure across three Centers for Disease Control and Prevention (CDC) Public Health Infrastructure Grant (PHIG) strategies: Workforce, Foundational Capabilities, and Data Modern…

Making a Difference in Real-World Bioethics Dilemmas Grants is sponsored by The Greenwall Foundation. This program supports research to help resolve important emerging or unanswered bioethics problems in clinical, biomedical, or public health decision-making, policy, or practice. Projects may be empirical, conceptual, or normative and aim for real-world, practical impact. While not exclusively AI-focused, AI ethics can be a relevant area within bioethics.

Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health. This Notice of Funding Opportunity (NOFO) promotes innovative analysis and integration of NIH Common Fund data sets to advance biomedical research. AI and machine learning are frequently used for complex data analysis and integration.

Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3, Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) (NCI also participating). This funding opportunity supports the development of biomarkers or clinical outcomes from digital health technology for remote monitoring in clinical trials.

Strengthening Global Health Security by improving public health capacity to detect, notify, and respond to disease outbreaks globally (Estimated Post Date: April 24, 2026) is sponsored by Centers for Disease Control and Prevention-GHC. This Notice of Funding Opportunity (NOFO) is intended to support global health security partners in developing or continuing the implementation of surveillance activities.

Strengthening Public Health Surveillance Systems for Global Health Security is sponsored by Centers for Disease Control-GHC. This Notice of Funding Opportunity (NOFO) focuses on protecting and improving public health globally by strengthening public health surveillance systems, improving the surveillance workforce, enhancing the interface between disease surveillance and laboratory systems, reinforcin…

Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases is sponsored by Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). This cooperative agreement seeks to enhance the nation's ability to prevent, detect, and respond to infectious disease threats by supporting clinicians, healthcare professionals, healthcare systems, institutions, and organizations involved in patient care, public health, and inf…

Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases (CDC-RFA-JG-26-0056) is sponsored by Centers for Disease Control and Prevention (CDC). This Notice of Funding Opportunity (NOFO) from the CDC aims to strengthen national capacity to prevent, detect, and respond to infectious disease threats through national partnerships. Activities will focus on improving public health laboratory systems, workforce, biorisk management, emergency laboratory preparedness, and enhancing diagnostic capacity via rapid tests for low-resource settings and genomic sequencing for pathogens of pandemic potential.

Global Health Security: Strengthening Public Health Surveillance Systems is sponsored by Centers for Disease Control-GHC. This Notice of Funding Opportunity (NOFO) aims to protect and improve public health globally by strengthening public health surveillance systems, improving the public health surveillance workforce, enhancing electronic disease surveillance platforms, and reinforcing emergency surveillance preparedness. Activities will build and improve regional and country capacities to detect, respond, control, and prevent infectious diseases and emerging threats, including in developing countries and villages.

Global Health Security (GHS) through implementation of programs and activities that focus on protecting and improving health globally through partnerships with Ministries of Health and other governmental institutions (CDC-RFA-JG-26-0056) is sponsored by Centers for Disease Control-GHC. This Notice of Funding Opportunity (NOFO) aims to build upon CDC-funded activities to support Global Health Security (GHS) by implementing programs and activities focused on protecting and improving global health through partnerships with Ministries of Health and other governmental institutions. It seeks to improve prevention of avoidable epidemics, rapidly detect threats early, and respond rapidly and effectively to public health threats of international concern.

Global Health Security: Expanding Efforts and Strategies to Protect and Improve Public Health Globally (CDC-RFA-JG-26-0056) is sponsored by Centers for Disease Control and Prevention (CDC). This Notice of Funding Opportunity (NOFO) seeks to build upon activities funded by CDC to support Global Health Security (GHS) through implementation of programs and activities that focus on protecting and improving health globally through partnerships with Ministries of Health …

Enhancing sustainable health information and laboratory systems and networks for quality detection, management, and monitoring to end HIV and TB as public health threats in India is sponsored by Centers for Disease Control and Prevention (CDC). This opportunity from the CDC invites proposals to support India's Ministry of Health and Family Welfare (MOHFW), National AIDS Control Organization (NACO), and related institutions to strengthen health systems and laboratory networks for HIV, TB, and other public health concerns. It aligns with the America First Global Health Strategy to bolster health systems to prevent the global spread of infectious disease. Activities include optimizing health information and laboratory networks, enhancing surveillance, reinforcing biosafety and biosecurity, adopting innovative technologies, and strengthening the health workforce. Nonprofits are eligible.

The Research Scholars Program in HIV, offered by Gilead Sciences, supports emerging junior faculty investigators conducting HIV-related research. Since 2008, the program has invested over $36 million in more than 300 scholars. Each cycle awards six two-year grants of $90,000 each, totaling $180,000 per scholar. Eligible applicants are junior faculty at early career stages seeking to establish independent research programs in HIV prevention, treatment, or related biomedical sciences. The next deadline is June 25, 2026. This program is ideal for academic researchers looking to build a foundation in HIV science with the backing of a major pharmaceutical funder.

CDC-RFA-JG-26-0058: Strengthening Public Health Laboratory Systems is sponsored by Centers for Disease Control and Prevention (CDC). This NOFO aims to protect and improve global public health by strengthening laboratory systems, improving the public health laboratory workforce, improving bio risk management, reinforcing emergency laboratory preparedness, enhancing laboratory quality management systems, and enhancing diagnostic capacity via rapid tests for low resource settings and genomic sequencing for pathogens of pandemic potential.

Global Health Security Partners' Surveillance Activities (CDC-RFA-JG-26-0113) is sponsored by Centers for Disease Control and Prevention (CDC). This Notice of Funding Opportunity (NOFO) supports global health security partners in developing or continuing surveillance activities to protect and improve public health globally. Activities include strengthening public health surveillance systems and workforce, improving the interface between surveillance and laboratory systems, reinforcing emergency surveillance preparedness, enhancing electronic disease surveillance platforms, and enhancing the use of surveillance data for public health action.

Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator is sponsored by Centers for Disease Control - NCCDPHP. This opportunity focuses on public health approaches to address Alzheimer's disease and related dementias, supporting initiatives like the National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerators.

Huddle Up for Health Community Health Equity Grant is sponsored by CareFirst BlueCross BlueShield. Huddle Up for Health Community Health Equity Grant is a grant from CareFirst BlueCross BlueShield, in partnership with the Baltimore Ravens, that funds Maryland nonprofits building or enhancing programming focused on mental health support, awareness, and advocacy.

Huddle Up for Health Community Health Equity Grant is a grant from CareFirst BlueCross BlueShield, in partnership with the Baltimore Ravens, that funds Maryland nonprofits building or enhancing programming focused on mental health support, awareness, and advocacy. The program prioritizes organizations working in the behavioral health space that also address upstream social, economic, and environmental drivers of health. Eligible applicants are Maryland-based 501(c)(3) nonprofits. Awards are up to $50,000, with the application deadline on May 5, 2026. Now in its third year, the program reflects a long-standing collaboration between CareFirst and the Ravens to advance community wellness and reduce health disparities.

Cures Within Reach – Clinical Trials to Validate AI-Driven Drug Repurposing is sponsored by Cures Within Reach. This grant supports investigator-initiated, proof-of-concept, Phase I or Phase IIA clinical trials to validate artificial intelligence (AI)-driven repurposing opportunities in any unsolved disease. The therapies supported by AI models must already be approved, and eligible trials must include AI-generated data as part of the preclinical support for the trial. This could be highly relevant for identifying existing drugs that AI suggests could be effective in colorectal cancer.

Peer Reviewed Cancer Research Program (PRCRP) is sponsored by U.S. Department of Defense, Congressionally Directed Medical Research Programs (CDMRP). The PRCRP supports high-impact research across various cancer types, including colorectal cancer. It funds hypothesis-driven, innovative, and mature research projects, and clinical trials that address critical scientific or clinical cancer issues and have the potential for major near-term impact. The program emphasizes innovation and relevance to military health.

Longevity Research Program is a grant from the Longer Life Foundation that funds academicians and scientists conducting fundamental research into factors that influence longevity, health, and wellness. The foundation's mission is to support studies that predict mortality and morbidity in select populations and identify factors that improve human lifespan and healthspan. Since its founding in 1998, the Longer Life Foundation has granted over $9.9 million to support more than 172 research projects. Grants fund researcher time, lab equipment, and supplies, with priority given to early-career researchers at the seedling stage of novel ideas. Letters of intent are due June 29, 2026. Eligible applicants are academicians and scientists engaged in fundamental longevity and health research.

Southern Illinois Healthcare Strategies is sponsored by Illinois Department of Public Health (IDPH). Funding supports the secondary prevention of individuals with a diagnosis of diabetes. IDPH will work with the grantee to improve screening reminders/prompts/alerts for complications related to diabetes, including diabetic retinopathy and chronic kidney disease within their electronic health record.

Community Clean Air Grant Program is sponsored by City of Boston Air Pollution Control Commission (APCC). This program funds nonprofit organizations for community-based projects that reduce, mitigate, or monitor air pollution in the City of Boston. It aims to improve air quality and reduce exposure risks while raising awareness for air pollution-related environmental and public health challenges, contributing to Boston's carbon neutrality goal by 2050. Projects should directly address air pollution through mitigation, abatement, monitoring, or utilizing local air quality data to educate the community.

Biotechnology Applications from Space for Earth is sponsored by National Aeronautics and Space Administration (NASA). This STTR program seeks proposals to accelerate commercial scale production in space of superior biotechnology materials and products for Earth applications that meet FDA standards. A special focus is on projects that use space to accelerate solutions to intractable childhood diseases, including the use of Artificial Intelligence (AI)/Machine Learning (ML) analyses and modeling of microgravity dynamics for medical applications and analysis of biomedical spaceflight results.

Bio-Medical Instruments mini-grant is sponsored by Foundation for Neurofeedback and Neuromodulation Research. This grant specifically focuses on projects that contribute to the knowledge of basic processes involved in neuromodulation methods and technologies or understanding the clinical effects of neurofeedback or other neuromodulation methods. This directly aligns with biomedical devices for biofeedback.

FY27 GLIA-CTN Career Development Award is sponsored by Rare Diseases Clinical Research Network (RDCRN) - GLIA-CTN. This is a mentored award designed to provide protected time for clinically trained individuals to receive supervised training in biomedical research related to leukodystrophies. Argininosuccinic aciduria can have neurological implications, and gene therapy research that touches on neurological aspects or underlying metabolic pathways relevant to leukodystrophies could be a fit.

Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator (Forecasted CDC-RFA-DP-26-0227) is sponsored by Centers for Disease Control and Prevention (CDC). Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator (Forecasted CDC-RFA-DP-26-0227) is sponsored by Centers for Disease Control and …

The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required) is sponsored by National Cancer Institute (NCI). This opportunity from the National Cancer Institute (NCI) is for the Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations. This is a cooperative agreement (UM1) and requires a clinical trial.

The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratory (U24 Clinical Trial Not Allowed) is sponsored by National Cancer Institute (NCI). This opportunity from the National Cancer Institute (NCI) is for the Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratory. This is a cooperative agreement (U24) and does not allow clinical trials.

Fiscal Year (FY) 2026 Expanding Nutrition Services (ENS) is sponsored by Health Resources and Services Administration (HRSA). This funding will support HRSA-funded health centers in expanding access to nutrition services and food-based interventions within primary care settings. The goal is to prevent and manage chronic diseases such as obesity, heart disease, and diabetes. Applicants must increase the number of nutrition services patients or visits.

Mallinckrodt Foundation Biomedical Early-stage Investigator Grants is a grant from the Edward Mallinckrodt, Jr. Foundation that funds early-career biomedical researchers at American academic institutions. The program provides startup support to help investigators advance projects to the point where R01 or other independent funding can be secured. Recipients receive $75,000 annually for up to three years (grants are not renewable). Eligible applicants are tenure-track faculty in their first through fourth year who hold an M.D. and/or Ph.D. degree and do not currently have R01 or equivalent independent funding. Institutions may submit one proposal per application session. The deadline is July 1, 2026.

The Patrick J. McGovern Foundation Data Practice Accelerator provides grants of up to $125,000 to nonprofits with complex datasets that are ready to deepen their data practice and build toward AI readiness. This program is distinct from the foundation's larger AI Fluency and Capacity Building grants ($100K-$750K) and focuses specifically on helping organizations develop the data infrastructure, skills, and practices needed to responsibly adopt AI tools. The accelerator supports organizations across the foundation's priority areas including climate action, health equity, economic solidarity, human rights, and crisis response. Applications are accepted on a rolling basis with a current deadline of July 1, 2026. The McGovern Foundation, with $1.6+ billion in assets and $75.8 million in FY2025 charitable spend, is one of the largest private funders of AI-for-good initiatives globally.

NAA Research Grant Program is sponsored by National Aphasia Association. The National Aphasia Association (NAA) offers research grants, including the Outdrive Aphasia Primary Progressive Aphasia (PPA) Research Grant focusing on interventions, care models, and support for individuals and families with PPA, and the Davetrina Seles Gadson Health Equity Mini-Grants for projects addressing equity and inclusion in aphasia care.

Pediatric Cancer Research Foundation Translational Research Grants is sponsored by Pediatric Cancer Research Foundation (PCRF). This grant primarily funds new research protocols and therapies that hold promise for improved outcomes and accelerates cures from the laboratory bench to the bedside of children and teens with high-risk cancers. It supports programs involving open, multi-institutional cancer clinical trials or consortia that implement new approaches to therapy.

Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator (Forecast) is sponsored by Centers for Disease Control and Prevention (CDC). This forecasted opportunity promotes brain health, addresses cognitive impairment, and supports caregivers using evidence-based approaches.